<i>Collinsella aerofaciens</i> as a predictive marker of response to probiotic treatment in non-constipated irritable bowel syndrome.

"data availability statement metataxonomic raw sequencing data are available as fastq files in the european nucleotide archive (ena) of the european bioinformatics institute under the accession code prjeb56302. data availability statement metataxonomic raw sequencing data are available as fastq files in the european nucleotide archive (ena) of the european bioinformatics institute under the accession code prjeb56302"

"Disclosure statement No potential conflict of interest was reported by the author(s)."

"Competing interests: SG received research/educational grants and/or speaker/consultation fees from several food and pharmaceutical companies, including Sofar S.p.A. WF, an employee of Sofar S.p.A., which financially supported the study. The probiotic product used in this study was commercialized by a company that financially supported the study."